Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
- PMID: 9090379
- DOI: 10.1038/ng0497-356
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
Abstract
Deletions involving regions of chromosome 10 occur in the vast majority (> 90%) of human glioblastoma multiformes. A region at chromosome 10q23-24 was implicated to contain a tumour suppressor gene and the identification of homozygous deletions in four glioma cell lines further refined the location. We have identified a gene, designated MMAC1, that spans these deletions and encodes a widely expressed 5.5-kb mRNA. The predicted MMAC1 protein contains sequence motifs with significant homology to the catalytic domain of protein phosphatases and to the cytoskeletal proteins, tensin and auxilin. MMAC1 coding-region mutations were observed in a number of glioma, prostate, kidney and breast carcinoma cell lines or tumour specimens. Our results identify a strong candidate tumour suppressor gene at chromosome 10q23.3, whose loss of function appears to be associated with the oncogenesis of multiple human cancers.
Similar articles
-
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.Cancer Res. 1997 Sep 1;57(17):3657-9. Cancer Res. 1997. PMID: 9288766
-
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.Cancer Res. 1997 Dec 1;57(23):5221-5. Cancer Res. 1997. PMID: 9393738
-
Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.Oncogene. 1998 Jan 8;16(1):89-93. doi: 10.1038/sj.onc.1201512. Oncogene. 1998. PMID: 9467947
-
Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32. doi: 10.1093/jnci/91.22.1922. J Natl Cancer Inst. 1999. PMID: 10564676 Review.
-
Phosphatases and tumorigenesis.Curr Opin Oncol. 1998 Jan;10(1):88-91. doi: 10.1097/00001622-199801000-00014. Curr Opin Oncol. 1998. PMID: 9466490 Review.
Cited by
-
Suppressive cancer nonstop extension mutations increase C-terminal hydrophobicity and disrupt evolutionarily conserved amino acid patterns.Nat Commun. 2024 Oct 25;15(1):9209. doi: 10.1038/s41467-024-52779-4. Nat Commun. 2024. PMID: 39448564 Free PMC article.
-
Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma.J Clin Invest. 2024 Oct 1;134(22):e178628. doi: 10.1172/JCI178628. J Clin Invest. 2024. PMID: 39352749 Free PMC article.
-
Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway.Am J Cancer Res. 2024 Aug 25;14(8):3757-3772. doi: 10.62347/SQJB1901. eCollection 2024. Am J Cancer Res. 2024. PMID: 39267674 Free PMC article.
-
Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w. Signal Transduct Target Ther. 2024. PMID: 39138146 Free PMC article. Review.
-
PTEN-Long inhibits the biological behaviors of glioma cells.Am J Transl Res. 2024 Jul 15;16(7):2840-2851. doi: 10.62347/QHCA5842. eCollection 2024. Am J Transl Res. 2024. PMID: 39114725 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
